XLU Stock UPDATES Utilities Select Sector SPDR (XLU) 41.44 08/10/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Utilities Select Sector SPDR (XLU) 41.44 $XLU

Year's Gains In Utilities Are Fading Away
at Investor's Business Daily - Thu Aug 07, 5:02PM CDT
Utility stocks are trending downward as the year's rally in the sector quickly fades. Although utilities often perform relatively better than most other stocks in bumpy markets, the sector's had no such strength lately. IBD's Utility Leaders screen...

Declining Utility Stocks Signal Gains Ahead for Russell 2000
at The Street - Tue Aug 05, 12:10PM CDT
The recent shift of funds from utility stocks to the Russell 2000 index may signal a stronger risk appetite for U.S. equities.

Thar She Blows, Volume 2: Time to Closely Read the S&P 500 Signals
at The Street - Fri Aug 01, 4:27PM CDT
The stock indexes tool another hit Friday on huge downside volume.

Rates Will Rise as Labor Market 'Slack' Outweighed by Stability
at The Street - Fri Aug 01, 1:51PM CDT
The labor market may still have slack, but employment stabilization will lead to higher rates.

How Many More 100-Point-Swing Days on the DJIA Can You Take?
at The Street - Mon Jul 28, 4:43PM CDT
The stock indexes fluctuated wildly on Monday as the hedge funds trading the S&P between the daily trading range.

Skip Sales Load: 3 Top No-Load Funds to Buy - Best of Funds
Zacks Equity Research - Zacks Investment Research - Fri Jul 25, 10:59AM CDT
Energy, Utilities and Healthcare sectors currently fill the top 3 slots for the best gains year to date among the S&P 500 industry groups. We are going to share with you 3 Zacks #1 (Strong Buy) no-load funds from each sector.

Option Traders Bet Against Utilities Rally: 3 Funds to Sell - Best of Funds
Zacks Equity Research - Zacks Investment Research - Wed Jul 16, 3:45PM CDT
Utilities have been the top performing sector among the S&P 500 industry groups this year. However,...

Forget Interest Rates, MLPs Will Continue to Make You Money
Joseph Hogue, The Motley Fool - Motley Fool - Mon Jul 14, 2:47PM CDT
Even minutes from the most recent meeting of the Federal Open Market Committee, signaling an October end to bond purchases, were not enough to move treasury rates out of their funk. Yields have hovered around 2.5% for two months and are down...

Russell 2000 Stays Down for the Day and Year as Majors Gain
at The Street - Fri Jul 11, 5:12PM CDT
The stock market was higher on Friday in slow trading, but the Russell 2000 was again on the downside and negative for the 2014. This is a red flag.

Can Utility ETFs Regain Their Lost Momentum? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Jul 09, 11:00AM CDT
Utility ETFs were star performers to begin the year, but they have stumbled lately. Can they turn it around in the second half of 2014?

How to Reap Big Dividends From the Utilities Sector
Selena Maranjian, The Motley Fool - Motley Fool - Mon Jul 07, 4:45PM CDT
Source: DTEEnergy.com. Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you. If you'd like to add some utility companies to your portfolio but don't have the time or expertise to hand-pick a few, the ...

Utilities, Energy, Health Care Are the ETFs to Beat This Year
at The Street - Thu Jul 03, 10:10AM CDT
I track 11 exchange-traded funds, and the best year-to-date performer is utilities, while health care set an all-time high on Wednesday.

'Fast Money' Recap: Let Your Winning Trades Keep Running
at The Street - Wed Jul 02, 4:00AM CDT
The trading panel discussed yet another closing high for the S&P 500 and DJIA plus what they are buying and selling.

Why NextEra Energy's Momentum Will Continue Into the Third Quarter
at The Street - Tue Jul 01, 5:00AM CDT
Over the last six quarters, the stock has closed higher after reporting earnings.

This U.S. Stock Market Is Not Dealing in Reality as It Moves Higher
at The Street - Mon Jun 30, 4:32PM CDT
The stock market on Monday closed out the second quarter in mixed fashion. The DJIA is oversold while the Nasdaq is overbought.

XLU, PCG, PPL, PEG: ETF Inflow Alert
ETFChannel.com - Thu Jun 26, 10:03AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Utilities Select Sector SPDR Fund where we have detected an approximate $606.6 million dollar inflow -- that's a 9.8%...

A Stock Market Selloff With Some Volume and Power Behind It
at The Street - Tue Jun 24, 4:20PM CDT
The stock indexes closed down on Tuesday after an intraday turn from the upside. The downside volume was big in comparison to the upside volume for the past month.

Trading Index ETFs: Semiconductors and Utilities Are in the Lead
at The Street - Fri Jun 20, 9:23AM CDT
Among eight exchange-traded funds that track major market indices, the headliners are the ones that track semiconductors, utilities and transports.

Can the Stock Market Continue to Rise With Contrary Indicators?
at The Street - Thu Jun 19, 4:40PM CDT
The stock market continues to go higher against the backdrop of accelerating inflation and growth slowing indicators. What will ultimately stop the advance?




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 87

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 399

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 448

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Segway Powersports Dominates Baja 1000 with Class 2 Sweep

Updated Category News Views 72

Catching the eye of any betting man, Segway Powersports has turned its maiden outing at the relentless SCORE Baja 1000 into a rousing victory. Their arrival on this unforgiving stage with a one-two in Class 2 isn't just a lucky roll—you don't chance upon podium sweeps in such gritty contests. Dissecting the Drive: Commitment and Coordination Unfolding across Baja's...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 0

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 14

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 412

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 89

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 284

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

O-I Glass Announces Participation in Citi’s 2025 Conference

Updated Category News Views 208

O-I Glass Participation in the 2025 Basic Materials Conference PERRYSBURG, Ohio — O-I Glass, Inc., known for its commitment to creating exceptional glass products, is set to participate in the upcoming Citi’s 2025 Basic Materials Conference. This significant event will take place on a Wednesday in December, and features notable presentations from O-I's leadership....

Continue Reading
Osmium Partners Proposes Strategic Plan for Articore Growth

Updated Category News Views 104

Osmium Partners Proposes a Four-Step Plan for Articore Osmium Partners has recently made headlines with their proposal for Articore, aiming to elevate shareholder value through a methodical four-step approach. This initiative is driven by Osmium's belief that Articore's current management strategy lacks direction and has resulted in missed opportunities for growth and...

Continue Reading
Amplify Energy Set to Shine at EnerCom Denver Conference 2025

Updated Category News Views 135

Amplify Energy’s Participation in EnerCom Denver Conference Amplify Energy Corp. is gearing up to participate in the renowned annual EnerCom Denver Conference in 2025. This event, known for bringing together leading experts and investors in the energy sector, offers Amplify a prime platform to showcase its strategic initiatives and growth potential. Focus on Investor...

Continue Reading
Safe Life Expands CPR Training and AED Services through Acquisition

Updated Category News Views 197

Safe Life Strengthens National Coverage for Life-Saving Training Safe Life has made a significant move by acquiring HeartCert, a company known for its specialization in automated external defibrillators (AEDs) and CPR training. This acquisition allows Safe Life to broaden its reach into the Midwest, enhancing its commitment to providing life-saving training and equipment...

Continue Reading
Express Scripts Challenges FTC's Drug Pricing Conclusions

Updated Category News Views 106

Express Scripts Files Lawsuit Against the FTC Express Scripts, a major player in the pharmacy benefit manager sector, has recently taken legal action against the U.S. Federal Trade Commission (FTC). This lawsuit stems from a report that criticizes the role of pharmacy benefit managers in the pricing of medications. Express Scripts contends that the report's conclusions...

Continue Reading